The Pharmacogenomics Research Network (PGRN) is currently funded solely by a grant from the United States National Institutes of Health (NIH), which will expire on June 30, 2020. After that date, the PGRN will lose all resources and will be unable to continue any functions unless an alternate mechanism of financial support is identified. The PGRN Steering Committee, with feedback from PGRN members, believes that the PGRN serves a vital function of bringing together researchers in pharmacogenomics and would like to see its activities continue, even without NIH support. The Steering Committee has decided that the best way forward is to transition the PGRN to an independent scientific society, supported by member dues. This independent scientific society will continue many of the functions of the current PGRN, including web-based Research in Progress Seminars (RIPS), organizing symposia or poster sessions at ASHG or other meetings, hosting member calls, and maintaining the pgrn.org website.
The PGRN Steering Committee voted on the following annual dues structure for membership:
Founding Members- $300**
*$20 discount if you pay your dues by June 1, 2020
**Founding members will be listed on the PGRN website
In order for the scientific society to be financially viable, 73 members were needed to pay their membership dues by August 2020. If there were fewer than 73 members who join the society by that date, the PGRN could not continue. We are proud to announce we currently have over 125+ members and will host a poster session at the 2020 ASHG Annual Meeting, and RIPS and other activities will continue. Please use the link below to become a new PGRN member.
The PGRN-Hub has identified and hired a professional association manager to run the PGRN after NIH funding ends on June 30, 2020. The new scientific society has now been officially incorporated as a non-profit corporation based in the State of Florida, and approved for 501(c)(3) non-profit status with the U.S. Internal Revenue Service (IRS). The society also has a functioning bank account and a way to receive membership dues through an online portal. The transition Board of Directors for the society is comprised of the members listed below.
Future Board Members will be elected in accordance with the Bylaws.
President- Kathy Giacomini
Vice President- Andrew A. Monte
Secretary- Dan Roden
Treasurer- Ron Krauss
Councilors- Mary Relling, Alan Shuldiner, Minoli Perera
PharmGKB- Teri Klein
CPIC- Kelly Caudle
PharmVar- Andrea Gaedigk